Header Logo

Connection

MICHAEL R MIGDEN to Infusions, Intravenous

Back to Details
This is a "connection" page, showing publications MICHAEL R MIGDEN has written about Infusions, Intravenous.
MICHAEL R MIGDEN
Connection Strength
0.036
Infusions, Intravenous
  1. Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing. J Immunother Cancer. 2020 06; 8(1).
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.